Chemed (CHE) to Release Earnings on Wednesday

Chemed (NYSE:CHE - Get Free Report) will likely be releasing its earnings data after the market closes on Wednesday, April 23rd. Analysts expect Chemed to post earnings of $5.59 per share and revenue of $641.78 million for the quarter. Parties that wish to register for the company's conference call can do so using this link.

Chemed Price Performance

Shares of NYSE CHE traded down $0.86 during trading hours on Friday, hitting $580.52. 110,655 shares of the company's stock were exchanged, compared to its average volume of 97,957. The stock has a market capitalization of $8.48 billion, a price-to-earnings ratio of 29.33, a PEG ratio of 2.15 and a beta of 0.49. The company's 50-day moving average price is $586.31 and its 200-day moving average price is $567.45. Chemed has a 1-year low of $512.12 and a 1-year high of $623.61.

Chemed Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.34%. The ex-dividend date of this dividend was Monday, February 24th. Chemed's payout ratio is currently 10.05%.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on CHE. Royal Bank of Canada upped their price objective on shares of Chemed from $633.00 to $667.00 and gave the company an "outperform" rating in a research report on Friday, March 14th. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th.

Insider Activity at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business's stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $593.67, for a total value of $1,187,340.00. Following the sale, the chief executive officer now owns 102,679 shares of the company's stock, valued at $60,957,441.93. The trade was a 1.91 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 3.32% of the stock is currently owned by corporate insiders.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.